Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Grifols Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (77)
Cancellation by sponsor (15)
Australian Public Assessment Report (AusPAR) (4)
Cancellation or suspension (2)
Prescription medicine decision summary (2)
Prescription medicine registration (2)
Prescription medicine evaluation (1)

Date

2024 (4)
2023 (4)
2022 (13)
2021 (10)
2020 (8)
2019 (4)
2018 (2)
2017 (7)
2016 (5)
2015 (22)
2014 (3)
2013 (6)
2011 (4)
2010 (1)
2008 (5)
2006 (5)

Results for "[search-keyword]"

Search

Sponsor content

103 result(s) found, displaying 31 to 40

VeraSeal

12 November 2021

Prescription medicine decision summary

TGA decision: VeraSeal (human fibrinogen/ human thrombin) is approved to treat hemostasis.
VERASEAL (Grifols Australia Pty Ltd)

29 October 2021

Prescription medicine registration

Active ingredients: human fibrinogen; human thrombin.
PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial (305253)

1 July 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial.
Grifols Australia Pty Ltd - Thrombophilia and coagulation inhibitor IVDs Cancelled under Section 41GL(d) of the Act

9 October 2020

Cancellation by sponsor

Requested by Grifols Australia Pty Ltd
Grifols Australia Pty Ltd - Coagulation factor IVDs Cancelled under Section 41GL(d) of the Act

9 October 2020

Cancellation by sponsor

Requested by Grifols Australia Pty Ltd
Grifols Australia Pty Ltd - Fibrinolysis IVDs Cancelled under Section 41GL(d) of the Act

9 October 2020

Cancellation by sponsor

Requested by Grifols Australia Pty Ltd
Grifols Australia Pty Ltd - General coagulation IVDs Cancelled under Section 41GL(d) of the Act

9 October 2020

Cancellation by sponsor

Requested by Grifols Australia Pty Ltd
Grifols Australia Pty Ltd - Specimen receptacle IVDs Cancelled under Section 41GL(d) of the Act

9 October 2020

Cancellation by sponsor

Requested by Grifols Australia Pty Ltd
Grifols Australia Pty Ltd - Coagulation calibrator/control IVDs Cancelled under Section 41GL(d) of the Act

9 October 2020

Cancellation by sponsor

Requested by Grifols Australia Pty Ltd
Grifols Australia Pty Ltd - Coagulation-related IVDs Cancelled under Section 41GL(d) of the Act

9 October 2020

Cancellation by sponsor

Requested by Grifols Australia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.